GH Research (GHRS) Receivables - Other (2023 - 2025)
GH Research (GHRS) recorded quarterly Receivables - Other of $1.2 million in Q4 2025, down 26.8% quarter-over-quarter from $1.6 million in Q4 2024, and down 26.8% on a YoY basis from $1.6 million in Q4 2024.
GH Research (GHRS) Receivables - Other (2023 - 2025) Analysis & Trends
GH Research's Receivables - Other history runs 3 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Receivables - Other fell 26.8% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (down 26.8% YoY), while the FY2025 annual figure was $1.2 million, down 26.8% from the prior year.
- Receivables - Other was $1.2 million for Q4 2025 at GH Research, down from $1.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.6 million in Q4 2024 to a low of $119000.0 in Q4 2023.
- Historically, Receivables - Other has averaged $953000.0 across 3 years, with a median of $1.2 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 1229.41% in 2024, then retreated 26.8% in 2025.
- A 3-year view of Receivables - Other shows it stood at $119000.0 in 2023, then surged by 1229.41% to $1.6 million in 2024, then retreated by 26.8% to $1.2 million in 2025.
- The last three Receivables - Other figures came in at $1.2 million (Q4 2025), $1.6 million (Q4 2024), and $119000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 119,000.00 |
| Dec 31, 2023 | 119,000.00 |